Common Contracts
4 similar Employment Agreement contracts by Acumen Pharmaceuticals, Inc.
EMPLOYMENT AGREEMENTEmployment Agreement • August 16th, 2021 • Acumen Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Virginia
This EMPLOYMENT AGREEMENT (the “Agreement”) is entered into effective May 15, 2021 (the “Effective Date”), by and between Wm. Matthew Zuga (the “Executive”) and Acumen Pharmaceuticals, Inc. (the “Company”) and supersedes and replaces any prior consulting agreement or employment letter between the Parties and any of their affiliates, including that certain Consulting Agreement between the Company and Executive dated August 16, 2019, that certain Employment Agreement between Executive dated January 1, 2021, that certain Letter Agreement between the Company and Executive dated March 11, 2021 .
EMPLOYMENT AGREEMENTEmployment Agreement • May 14th, 2021 • Acumen Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Indiana
This EMPLOYMENT AGREEMENT (the “Agreement”) is entered into effective January 1, 2021 (the “Effective Date”), by and between Russell Barton (the “Executive”) and Acumen Pharmaceuticals, Inc. (the “Company”) and supersedes and replaces any prior consulting agreement or employment letter between the Parties and any of their affiliates.
EMPLOYMENT AGREEMENTEmployment Agreement • May 14th, 2021 • Acumen Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Virginia
This EMPLOYMENT AGREEMENT (the “Agreement”) is entered into effective January 1, 2021 (the “Effective Date”), by and between Daniel J. O’Connell (the “Executive”) and Acumen Pharmaceuticals, Inc. (the “Company”) and supersedes and replaces any prior consulting agreement or employment letter between the Parties and any of their affiliates.
EMPLOYMENT AGREEMENTEmployment Agreement • May 14th, 2021 • Acumen Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Indiana
This EMPLOYMENT AGREEMENT (the “Agreement”) is entered into effective January 1, 2021 (the “Effective Date”), by and between Eric Siemers, MD (the “Executive”) and Acumen Pharmaceuticals, Inc. (the “Company”) and supersedes and replaces any prior consulting agreement or employment letter between the Parties and any of their affiliates.
